http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SK-288226-B6

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a2498873400d660437a83953bdfbe20f
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
filingDate 2010-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_740b1af564b0d1ae894f22c00cf54258
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05ea17ec44471ee1b27c2821a537837d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8a54b6e007534bc39de67547da470ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bcc7fe784e9705eecdaa53118c2247e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f841ac8420d21b0bbcf174d4d786d57f
publicationDate 2014-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber SK-288226-B6
titleOfInvention The crystalline alpha-form of Imatinib mesylate with the new habit and the method for its preparation and use
abstract A crystalline alpha form of Imatinib mesylate with a new habit, a method for its preparation and its use for therapeutic purposes is described.
priorityDate 2010-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8738
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454269980
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554878
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1775
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18366337
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505403
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6405
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451609951
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8114
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419488561
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408196011
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452223878
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123596
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426685193
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11428
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31272
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422998970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137814
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534036
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17869655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420167136
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420431015
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11732
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531072
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14495544
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7996
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11146
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520672
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414028460
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419515061
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18676734
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420167171
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544127
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419509861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523117
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22112625

Total number of triples: 61.